Jones Financial Companies
NVRO

Jones Financial Companies’s NEVRO CORP. NVRO Stock Holding History

Jones Financial Companies’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-50
Closed -$265 – 3526
2024
Q3 		$265 Buy
+50
New +$350 ﹤0.01% 2929

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Jones Financial Companies's NVRO Position: Q4 2024 in Review

Jones Financial Companies sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 50 shares — an estimated $265 sold.

Jones Financial Companies first reported a position in NVRO in Q3 2024 and held it in 1 quarter. The position peaked at $265 in Q3 2024. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Jones Financial Companies reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Jones Financial Companies sold 50 NEVRO CORP. shares in Q4 2024, an estimated $265.
  • Jones Financial Companies first reported a position in NEVRO CORP. in Q3 2024 and held it in 1 quarter.
  • Jones Financial Companies's NEVRO CORP. position peaked at $265 in Q3 2024.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Jones Financial Companies's 13F filing for Q4 2024, filed 6 Feb 2025.